In 2010, Wu et al. demonstrated that knockdown of GRP78 in tumor-initiating (CSC-like) cells from head and neck cancer impairs their self-renewing capacity, tumorigenic potential, and expression of stemness-related genes, while reducing the SP cell’s proportion and enhancing apoptosis [213]. This evidence concerns the gene HSPA5 and neoplasm.